|
|
|
|
|
| As already announced early February, Lübeck-based Drägerwerk AG has achieved its 2001 target by posting sales of €1.26 billion (up from €1.14 billion). Following the tough consolidation year of 2000 with its heavy restructuring expenses, the Dräger Group in 2001 was back in the black by €10 million. All of the divisions contributed.
|
|
| As stated by the Executive Board of this medical, safety and aerospace technology group, in 2001 Dräger Medical quadrupled its EBIT from €9.1 million to €39.0 million and boosted sales by 10 percent to €805 million. Dräger Safety improved on its year-earlier sound EBIT, by 10 percent to €30.3 million, its division sales gaining 11 percent to €425 million, while the smallest of the divisions, Dräger Aerospace, despite the turbulences within its sector, repeated its previous year’s EBIT of €1 million, with sales up 12 percent to €28 million. The EBIT for the Group as a whole amounted to €49.5 million (up from €30.1 million excl. the restructuring expenses of €47.7 million).
|
|
| The Medical and Safety divisions in 2001 succeeded in once again expanding and strengthening business outside of Germany. In Asia, North America, and Europe, Dräger Medical showed better-than-average growth in its core businesses (anesthesia, emergency care, neonatal care, pre- & post-hospital care, medical equipment & systems). These are regions where Dräger Safety likewise showed steep growth, especially with its stationary gas detection units and systems, its compressed-air respirators (meanwhile world market leader) and its Alcotest family. Both divisions outpaced the market in these regions.
|
|
| The Executive Board will propose to the Supervisory Board and the annual stockholders’ meeting on June 14, 2002, to pay a cash dividend of €0.13 per common share, €0.13 per preferred share plus an additional €0.13 as cumulative dividend (which could not be paid in 2001). In line with the tenfold par value, holders of participation certificates will then receive €1.30 (10 times the preferred dividend). Under the cumulative right of series D participation certificates, an additional dividend of €1.30 will be distributed for the previous, non-dividend year. Holders of series A and K participation certificates received the year before the guaranteed dividend of €1.30 and, therefore, no subsequent payment is required.
|
|
|
| Drägerwerk AG’s CEO Theo Dräger expects the Dräger Group to again show profitable growth, with sales budgeted to gain over 5 percent and earnings appreciably higher. The Group has got off to a good start in the early months of fiscal 2002, with the product, market, and cost-control drives continuing on track throughout. In an effort to sustain this profitability improvement and in order to secure its core Medical and Safety competencies, the company does not rule out the option of opportune takeovers.
|
|
|
|
|
|
|
|
|
|
(c) Drägerwerk AG & Co. KGaA, 2007 |
|
 |
|
|
|
|
|
 |
|
